Clarke et al reported high CDC7 expression in nodular melanomas, atypical Spitz tumors, and superficial spreading melanomas (SSM) [10] and proposed that differences in CDC7 expression may facilitate in distinguishing melanomas from benign melanocytic lesions. This evidence concerns the gene CDC7 and melanoma.